X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (89993) 89993
Newsletter (29205) 29205
Book Review (16518) 16518
Publication (8104) 8104
Newspaper Article (3569) 3569
Magazine Article (800) 800
Conference Proceeding (538) 538
Book Chapter (442) 442
Trade Publication Article (186) 186
Transcript (151) 151
Book / eBook (141) 141
Web Resource (79) 79
Dissertation (56) 56
Government Document (37) 37
Streaming Video (31) 31
Data Set (18) 18
Reference (15) 15
Report (9) 9
Paper (7) 7
Journal / eJournal (6) 6
Presentation (2) 2
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (70115) 70115
humans (67266) 67266
antiviral agents (64891) 64891
antiviral agents - therapeutic use (36844) 36844
female (29603) 29603
male (29585) 29585
hiv (25340) 25340
adult (22801) 22801
health aspects (20189) 20189
research (20078) 20078
middle aged (19843) 19843
drug therapy (17933) 17933
aids (14286) 14286
infectious diseases (14049) 14049
highly active antiretroviral therapy (13692) 13692
animals (13484) 13484
infection (13129) 13129
virology (13048) 13048
care and treatment (12747) 12747
treatment outcome (12312) 12312
antiviral agents - pharmacology (11883) 11883
medical research (11375) 11375
hepatitis c virus (11061) 11061
analysis (10966) 10966
hepatitis c (10909) 10909
hiv infections - drug therapy (10187) 10187
medicine, experimental (10176) 10176
gastroenterology & hepatology (10081) 10081
hepatitis c, chronic - drug therapy (10021) 10021
virus diseases (9878) 9878
immunology (9835) 9835
drug therapy, combination (9787) 9787
pharmacology & pharmacy (9719) 9719
hiv infection (9715) 9715
antiviral agents - administration & dosage (9541) 9541
therapy (8997) 8997
aged (8824) 8824
anti-hiv agents (8798) 8798
viruses (8641) 8641
microbiology (8006) 8006
interferon (7992) 7992
risk factors (7470) 7470
interferon-alpha - therapeutic use (7343) 7343
human immunodeficiency virus--hiv (7273) 7273
infections (7205) 7205
hepatitis b (6882) 6882
antiviral agents - adverse effects (6735) 6735
hepatitis (6707) 6707
viral load (6576) 6576
hiv patients (6540) 6540
abridged index medicus (6476) 6476
ribavirin - therapeutic use (6329) 6329
adolescent (6257) 6257
universities and colleges (5912) 5912
genotype (5835) 5835
ribavirin (5834) 5834
aids/hiv (5774) 5774
drugs (5702) 5702
antiretroviral therapy (5636) 5636
hepacivirus - genetics (5454) 5454
hepatitis c - drug therapy (5345) 5345
mice (5318) 5318
antiviral therapy (5163) 5163
prevention (4935) 4935
dosage and administration (4923) 4923
young adult (4839) 4839
retrospective studies (4793) 4793
recombinant proteins (4714) 4714
reports (4617) 4617
drug resistance (4610) 4610
hepatitis b, chronic - drug therapy (4584) 4584
medicine, general & internal (4507) 4507
liver (4494) 4494
time factors (4483) 4483
influenza (4450) 4450
virus replication - drug effects (4441) 4441
medicine (4425) 4425
research article (4379) 4379
transplantation (4368) 4368
child (4358) 4358
hepatitis b virus (4289) 4289
virus-infection (4286) 4286
replication (4104) 4104
antiretroviral drugs (4081) 4081
mortality (4074) 4074
hepacivirus - drug effects (3984) 3984
human-immunodeficiency-virus (3974) 3974
rna (3947) 3947
biological response modifiers (3866) 3866
disease (3864) 3864
human immunodeficiency virus (3841) 3841
anti-hiv agents - therapeutic use (3799) 3799
article (3772) 3772
usage (3757) 3757
pharmaceutical industry (3725) 3725
genetic aspects (3657) 3657
cell line (3599) 3599
hiv infections - complications (3595) 3595
patients (3582) 3582
multidisciplinary sciences (3577) 3577
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (87) 87
Online Resources - Online (77) 77
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
UofT at Mississauga - Stacks (6) 6
UofT at Scarborough - Stacks (4) 4
Gerstein Science - Periodical Stacks (3) 3
Gerstein Science - Bindery (2) 2
Credit Valley Hospital - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Media Commons - Audio Visual (1) 1
New College (Ivey) - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Hospital Department (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (117313) 117313
French (1233) 1233
German (957) 957
Chinese (945) 945
Spanish (916) 916
Russian (811) 811
Japanese (708) 708
Korean (319) 319
Polish (270) 270
Italian (201) 201
Hungarian (125) 125
Dutch (107) 107
Portuguese (78) 78
Danish (69) 69
Swedish (51) 51
Romanian (50) 50
Czech (47) 47
Croatian (42) 42
Turkish (36) 36
Finnish (29) 29
Serbian (25) 25
Ukrainian (25) 25
Norwegian (24) 24
Hebrew (23) 23
Bulgarian (15) 15
Slovak (9) 9
Lithuanian (4) 4
Bosnian (3) 3
Icelandic (2) 2
Afrikaans (1) 1
Albanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by El-Sadr, W.M and Grund, B and Neaton, J.D and Neuhaus, J and Cohen, C.J and Darbyshire, J and Babiker, A and Emery, S and Lundgren, J.D and Phillips, A and Jensen, K.B and Gey, D.C and Borup, L and Pearson, M and Jansson, P.O and Jensen, B.G and Tverland, J and Juncker-Benzon, H and Fox, Z and Phillips, A.N and Babiker, A.G and Palfreeman, A.J and Fleck, S.L and Dodds, W and King, E and Cordwell, B and van Hooff, F and Collaco-Moraes, Y and Angus, B.J and Cooper, D.A and Drummond, F.M and Connor, S.A and Satchell, C.S and Gunn, S and Oka, S and Delfino, M.A and Merlin, K and McGinley, C and Gordin, F and Finley, E and Dietz, D and Chesson, C and Vjecha, M and Standridge, B and Bartsch, G and Duchene, A and George, M and Harrison, M and Krum, E and Larson, G and Miller, C and Nelson, R and Roediger, M.P and Schultz, T and Prineas, R and Campbell, C and Zhang, Z.M and Perez, G and Lifson, A and Duprez, D and Hoy, J and Lahart, C and Perlman, D and Price, R and Rhame, F and Sampson, J and Worley, J and Rein, M and Dersimonian, R and Brody, B.A and Daar, E.S and Dubler, N.N and Fleming, T.R and Freeman, D.J and Kahn, J.P and Kim, K.M and Medoff, G and Modlin, J.F and Moellering, R and Murray, B.E and Pick, B and Robb, M.L and Scharfstein, D.O and Sugarman, J and Tsiatis, A and Tuazon, C and Zoloth, L and Klingman, K and Lehrman, S and Lazovski, J and Belloso, W.H and Losso, M.H and Benetucci, J.A and Aquilia, S and Bittar, V and Bogdanowicz, E.P and Cahn, P.E and Casiró, A.D and Cassetti, I and Contarelli, J.M and ... and SMART Study Grp and SMART Study Group and The SMART Study Group
Annals of Internal Medicine, ISSN 0003-4819, 09/2008, Volume 149, Issue 5, pp. 289 - 299
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9904, pp. 1555 - 1563
Journal Article
1998, Medical perspectives series., ISBN 1859960707, xii, 161
Book
Clinical Infectious Diseases, ISSN 1058-4838, 6/2011, Volume 52, Issue 11, pp. 1374 - 1383
Background. The optimal time to initiate antiretroviral therapy (ART) in human immunodeficiency virus (HIV)—associated tuberculous meningitis is unknown.... 
Statistical median | HIV/AIDS | Antiretrovirals | Art therapy | Meningeal tuberculosis | HIV | Mortality | Random allocation | AIDS | Arts | HIV 1 | MORTALITY | SURVIVAL | THAILAND | INFECTIOUS DISEASES | HIV-INFECTION | ERA | ADOLESCENTS | CLINICAL-TRIALS | ADULTS | RISK | MICROBIOLOGY | IMMUNOLOGY | Lamivudine - administration & dosage | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Male | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Time Factors | Adult | Anti-Inflammatory Agents - administration & dosage | Female | HIV Infections - mortality | Antiretroviral Therapy, Highly Active - methods | Tuberculosis, Meningeal - mortality | Placebos - administration & dosage | Dexamethasone - administration & dosage | Tuberculosis, Meningeal - drug therapy | Benzoxazines - administration & dosage | Double-Blind Method | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Anti-HIV Agents - adverse effects | Treatment Outcome | Tuberculosis, Meningeal - complications | HIV Infections - complications | Antitubercular Agents - administration & dosage | HIV Infections - drug therapy | Antiviral agents | Care and treatment | Patient outcomes | Dosage and administration | Drug therapy | Health aspects | HIV infection | Comorbid patients | Tuberculous meningitis | Clinical trials | Antiretroviral drugs | Meningitis | Human immunodeficiency virus--HIV | Risk assessment | Medical treatment | Index Medicus
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 11/2016, Volume 165, Issue 9, pp. 625 - 634
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 07/2013, Volume 159, Issue 2, pp. 86 - 96
Background: Telaprevir (TVR) plus peginterferon-alpha 2a (PEG-IFN-alpha 2a) and ribavirin substantially increases treatment efficacy for genotype 1 chronic... 
Vertex pharmaceuticals and janssen pharmaceuticals | MEDICINE, GENERAL & INTERNAL | COINFECTED PATIENTS | MANAGEMENT | RECOMMENDATIONS | PREDICTORS | BOCEPREVIR | HCV | UPDATE | VIROLOGICAL RESPONSE | ASSOCIATION | INTERFERON PLUS RIBAVIRIN | HIV-1 | Recombinant Proteins - therapeutic use | Antiviral Agents - pharmacokinetics | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | Recombinant Proteins - pharmacokinetics | Recombinant Proteins - adverse effects | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Oligopeptides - therapeutic use | Ribavirin - pharmacokinetics | Interferon-alpha - pharmacokinetics | Adult | Anti-HIV Agents - therapeutic use | Female | Drug Therapy, Combination | Double-Blind Method | Antiviral Agents - therapeutic use | Oligopeptides - pharmacokinetics | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Polyethylene Glycols - pharmacokinetics | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Ribavirin - adverse effects | Antiviral Agents - adverse effects | HIV Infections - complications | Interferon-alpha - adverse effects | Antiviral agents | Patient outcomes | Dosage and administration | Drug therapy, Combination | Research | Hepatitis C | Drug therapy | HIV infection | Drugs | Clinical trials | Hepatitis | Side effects | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2013, Volume 59, Issue 3, pp. 434 - 441
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 2015, Volume 211, Issue 5, pp. 744 - 754
Journal Article